SCM LifeScience Co

SCM LifeScience Co Equity Growth

The Year-over-Year Equity Growth of SCM LifeScience Co (298060.KQ) as of Nov 19, 2026 is 154.40 %. In the previous year, Year-over-Year Equity Growth was -30.75 % — a change of -602.17% (higher).

Equity Growth

154.40 %

YoY

-602.17%

Last updated:

Year-over-Year Equity Growth of SCM LifeScience Co is 2025 154.40 % . Year-over-Year Equity Growth of SCM LifeScience Co was 2024 -30.75 % . It decreases by -602.17% higher compared to the previous year.

The SCM LifeScience Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
-414.41 KRW
Jan 1, 2019
137.78 KRW
Jan 1, 2020
274.35 KRW
Jan 1, 2021
-29.28 KRW
Jan 1, 2022
-45.06 KRW
Jan 1, 2023
-16.47 KRW
Jan 1, 2024
-30.75 KRW
Jan 1, 2025
154.40 KRW
The SCM LifeScience Co Equity Growth history
YEAREquity GrowthYoY
154.40 %-602.17%
-30.75 %+86.66%
-16.47 %-63.44%
-45.06 %+53.91%
-29.28 %-110.67%
274.35 %+99.12%
137.78 %-133.25%
-414.41 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCM LifeScience Co Stock analysis

What does SCM LifeScience Co do? SCM LifeScience Co Ltd is a biotechnology company headquartered in Incheon, South Korea. The company focuses on the development and production of cell therapy products, including adult stem cell therapies. It also engages in agency testing for cell production and quality assurance, as well as providing adult stem cell consulting services. Additionally, SCM LifeScience operates in the cosmetics and hair growth protein manufacturing sectors. The company has 55 full-time employees. SCM LifeScience completed its initial public offering (IPO) on June 17, 2020. Its stock is listed under the ticker 298060.KQ on the Korean stock exchange, with an ISIN code of KR7298060005. The company's website is http://www.scmlifescience.com/. SCM LifeScience operates within the healthcare sector, specifically within the biotechnology industry. It does not provide details on its founding year, specific product names, or financial figures beyond the IPO date and employee count. The company's activities span drug development for stem cell therapy, cell production testing, and manufacturing of related products. SCM LifeScience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCM LifeScience Co stock

Year-over-Year Equity Growth of SCM LifeScience Co is 154.40 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth SCM LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's SCM LifeScience Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — SCM LifeScience Co

All Key Metrics — SCM LifeScience Co